help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogino, K.
Right arrow Articles by Bilezikian, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogino, K.
Right arrow Articles by Bilezikian, J. P.

Endocrinology, Vol 136, 3024-3030, Copyright © 1995 by Endocrine Society


ARTICLES

The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein

K Ogino, D Burkhoff and JP Bilezikian
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

PTH and PTH-related protein (PTHrP) have been regarded to have positive inotropic effects on the heart as well as positive chronotropic and vasodilator effects. However, inotropy due to a direct effect of these peptides has not heretofore been distinguished from an indirect inotropic effect as a result of altered heart rate or coronary flow. The aim of this study was to determine whether PTH and PTHrP have direct inotropic effects in isolated perfused rat hearts. Three groups of hearts were studied; in all groups, hearts contracted isovolumically and were perfused with a constant coronary pressure. In the control group, heart rate, coronary flow, peak pressure (LVPmax), peak rate of rise of LV pressure (dP/dtmax), and peak intracellular calcium (measured by aequorin) all increased with PTH and PTHrP in a dose- dependent manner. When heart rate was fixed by pacing in a second group of rats, PTH and PTHrP increased coronary flow, LVPmax, and dP/dtmax significantly, indicating that inotropic actions were not mediated solely by chronotropic effects. However, when heart rate was fixed by pacing and, additionally, coronary flow was held constant (by maximal prevasodilation with nitroprusside) in a third group of rats, there was no significant effect of either PTH or PTHrP on LVPmax, dP/dtmax, or peak intracellular calcium. To demonstrate the responsiveness of this latter preparation to inotropic stimulation, the beta-adrenergic agonist, isoproterenol, increased LVPmax, dP/dtmax, and peak calcium even when heart rate was fixed and vasodilation was maximal. Thus, PTH and PTHrP are inotropic agents by virtue of their influence on coronary flow and heart rate, but not by any direct effect on contractile elements in the heart.


This article has been cited by other articles:


Home page
HeartHome page
T Sugimoto, T Tanigawa, K Onishi, N Fujimoto, A Matsuda, S Nakamori, K Matsuoka, T Nakamura, T Koji, and M Ito
Serum intact parathyroid hormone levels predict hospitalisation for heart failure
Heart, March 1, 2009; 95(5): 395 - 398.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Zittermann, S. S. Schleithoff, C. Gotting, O. Dronow, U. Fuchs, J. Kuhn, K. Kleesiek, G. Tenderich, and R. Koerfer
Poor outcome in end-stage heart failure patients with low circulating calcitriol levels
Eur J Heart Fail, March 1, 2008; 10(3): 321 - 327.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Gao and J. U. Raj
Parathyroid hormone-related protein-mediated responses in pulmonary arteries and veins of newborn lambs
Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L60 - L66.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Andersson, E. Rydberg, and R. Willenheimer
Primary hyperparathyroidism and heart disease -- a review
Eur. Heart J., October 2, 2004; 25(20): 1776 - 1787.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Fritsch, V. Lindner, S. Welsch, T. Massfelder, M. Grima, S. Rothhut, M. Barthelmebs, and J.-J. Helwig
Intravenous Delivery of PTH/PTHrP Type 1 Receptor cDNA to Rats Decreases Heart Rate, Blood Pressure, Renal Tone, Renin Angiotensin System, and Stress-Induced Cardiovascular Responses
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2588 - 2600.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Qian, M. C. Colbert, D. Witte, C.-Y. Kuan, E. Gruenstein, H. Osinska, B. Lanske, H. M. Kronenberg, and T. L. Clemens
Midgestational Lethality in Mice Lacking the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Is Associated with Abrupt Cardiomyocyte Death
Endocrinology, March 1, 2003; 144(3): 1053 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Jansen, P. Gres, C. Umschlag, F. R. Heinzel, H. Degenhardt, K.-D. Schluter, G. Heusch, and R. Schulz
Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H49 - H55.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Ogino, K. Ogura, Y. Kinugasa, Y. Furuse, K. Uchida, M. Shimoyama, T. Kinugawa, S. Osaki, M. Kato, Y. Tomikura, et al.
Parathyroid Hormone-Related Protein Is Produced in the Myocardium and Increased in Patients with Congestive Heart Failure
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4722 - 4727.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Shonni J. Silverberg;
Cardiovascular Disease in Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3513 - 3514.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Barletta, M. L. De Feo, R. Del Bene, C. Lazzeri, S. Vecchiarino, G. La Villa, M. L. Brandi, and F. Franchi
Cardiovascular Effects of Parathyroid Hormone: A Study in Healthy Subjects and Normotensive Patients with Mild Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1815 - 1821.
[Abstract] [Full Text]


Home page
NEJMHome page
G. J. Strewler
The Physiology of Parathyroid Hormone-Related Protein
N. Engl. J. Med., January 20, 2000; 342(3): 177 - 185.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. L. Selvais, J. E. Donckier, L. Rousseau, S. A. Ahn, J.-M. Ketelslegers, and M. F. Rousseau
Hemodynamic Effects of Parathyroid Hormone-Related Peptide: Is There a Pathophysiological Relevance?
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 1043a - 1044.
[Full Text]


Home page
CirculationHome page
M. Hara, Y.-M. Liu, L. Zhen, I. S. Cohen, H. Yu, P. Danilo Jr, K. Ogino, J. P. Bilezikian, and M. R. Rosen
Positive Chronotropic Actions of Parathyroid Hormone and Parathyroid Hormone–Related Peptide Are Associated With Increases in the Current, If, and the Slope of the Pacemaker Potential
Circulation, November 18, 1997; 96(10): 3704 - 3709.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Wolzt, L. Schmetterer, G. Dorner, G. Zelger, J. Entlicher, S. Kapiotis, and H.-G. Eichler
Hemodynamic Effects of Parathyroid Hormone-Related Peptide-(1-34) in Humans
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2548 - 2551.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K.-L. Laugwitz, H.-J. Weig, A. Moretti, E. Hoffmann, P. Ueblacker, I. Pragst, K. Rosport, A. Schomig, and M. Ungerer
Gene Transfer of Heterologous G Protein-Coupled Receptors to Cardiomyocytes : Differential Effects on Contractility
Circ. Res., April 13, 2001; 88(7): 688 - 695.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society